title: Beta-adrenergic receptor activation promotes process outgrowth in an embryonic rat basal forebrain cell line and in primary neurons.
abstract: A clonal cell line, AS583-8.E4.22, from the embryonic day 15 rat basal forebrain was established using retrovirus-mediated transduction of a temperature-sensitive mutant of the simian virus 40 (SV40) large tumour antigen. The cell line expresses cytoskeletal and neurotransmitter features indicative of neuronal commitment. In response to agents that increase intracellular cAMP, including forskolin and catecholamines, the cell line exhibits rapid process outgrowth and growth cone formation that does not require new gene expression or protein synthesis. The neurite outgrowth induced by catecholamines is mediated by beta 2-adrenergic receptors and is characterized by a rapid, reversible redistribution of filamentous actin. Neurons from primary cultures of embryonic day 15 basal forebrain were also found to respond to beta-adrenergic receptor agonists by enhancing growth cone formation. These results suggest that catecholamines provide cues that induce cytoskeletal rearrangements leading to neuronal process outgrowth and growth cone formation in the developing basal forebrain and possibly other neuronal progenitor cell populations. The neuronal basal forebrain cell line provides an ideal model to study the signalling mechanisms underlying the catecholamine-induced process outgrowth.
authors.affiliation: Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Kwon
authors.forename: E M
authors.initials: EM
authors.lastname: Eves
authors.forename: S
authors.initials: S
authors.lastname: Farrell
authors.forename: J
authors.initials: J
authors.lastname: Segovia
authors.forename: A J
authors.initials: AJ
authors.lastname: Tobin
authors.forename: B H
authors.initials: BH
authors.lastname: Wainer
authors.forename: M
authors.initials: M
authors.lastname: Downen
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics*; D002395:Catecholamines / Q000494:pharmacology*; D002460:Cell Line; D016922:Cellular Senescence; D000242:Cyclic AMP / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000096:biosynthesis; D004622:Embryo, Mammalian / Q000166:cytology / Q000187:drug effects; D005865:Gestational Age; D009154:Mutation; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D016548:Prosencephalon / Q000166:cytology / Q000187:drug effects* / Q000196:embryology; D051381:Rats; D011912:Rats, Inbred ACI; D014161:Transduction, Genetic
chemical_list: D000318:Adrenergic beta-Agonists; D000952:Antigens, Polyomavirus Transforming; D002395:Catecholamines; D003598:Cytoskeletal Proteins; D000242:Cyclic AMP